Delivery Order SPE2DB20D2014-SPE2DB24FB34U

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,760.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of March 29, 2024 and a ceiling value of $8,738.27. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $1,306.26 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $3,542.40, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $10,735.51 and a period of performance through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds an...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,902.80 contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a completion date of January 29, 2024 and a potential value of $7,850.12. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This award is part of a larger indefinite delivery contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $13,933.44 and a completion date of February 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $5,805.60 and a period of performance through April 1, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with a performance period through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $2,177.10 and a period of performance through March 21, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025,...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB34U
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $3,290.67 and a period of performance through March 19, 2024. This award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. AmerisourceBergen Corporation is the parent company of the prime contractor, AmerisourceBergen Drug Corp.

Generated 6/17/24, 9:02 AM